Treatment Free Remission After Combination Therapy With Ruxolitinib Plus Tyrosine Kinase Inhibitors
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Stanford University
M.D. Anderson Cancer Center
OHSU Knight Cancer Institute
University of Michigan Rogel Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
University Health Network, Toronto
Novartis